Platform capabilities, ready for partners.
GenREY's commercial offerings are organised by maturity — what is licensable today, what enters market in the next 24 months, and what is on the long-arc roadmap.
Today, partners can engage GenREY across hair-regeneration platform licensing (iREY / DAMI / exosome formulations), clinical-trial-readiness consulting in the GCC, rare-disease data-intelligence collaborations, and white-label biotech product development for clinical, veterinary and longevity markets.
Within 12–24 months, our pipeline opens regenerative-formulation supply agreements, GCC technology-transfer programmes, and translational commercialisation partnerships across the Vision 2030 / Qatar / UAE life-sciences corridors. Each engagement is structured to be sovereignty-respecting — IP portability, on-shore manufacturing options and trained local teams.
Long-arc, the platform unlocks regenerative breast & women's-health products, liver & organ-bioengineering services, anti-aging / longevity programmes and platform-level data products from our omics + AI infrastructure. Speak to our partnerships team about which window best fits your roadmap.
Built for partners, ministries, scientists and entrepreneurs.
iREY Hair Regeneration Platform
Patent-pending iREY device, DAMI delivery, linked serum and treatment protocols engineered for clinical and premium home use, with a built-in cartridge-subscription model.
Precision Regenerative Pharma
Follicle-selective androgen modulators and adjacent precision therapeutics — engineered for licensing and pharma co-development.
Clinical Trial Facilitation
GCC-ready clinical-trial infrastructure, recruitment, data governance and regulatory navigation across U.S. and Gulf authorities.
Sovereign Health Data Intelligence
National rare-disease registries, genomic data infrastructure and AI-driven precision-health insights for ministries, payers and pharma.
Biotech Licensing & White-Label
Out-licensing of IP, white-label translational programs and structured co-development with regional players (orthopedics, sports medicine, veterinary).
Anti-Aging & Longevity Programs
Premium longevity programs, mitochondrial regenerative protocols and concierge future-health offerings.
GCC Technology Transfer & Localization
Manufacturing localization, workforce training and Vision-2030 aligned national-capability building.
Where biology, robotics and sovereign science meet.
A glimpse into the GenREY platform — the labs, devices, infrastructure and partnerships powering the next decade of regenerative medicine.
Choose the engagement that fits.
From platform licensing to sovereign-scale joint deployment.